Shenzhen Salubris Pharmaceuticals Co., Ltd. (SHE: 002294)

Shenzhen Salubris Pharmaceuticals Revenue

Shenzhen Salubris Pharmaceuticals had revenue of 958.43M CNY in the quarter ending September 30, 2024, with 24.15% growth. This brings the company's revenue in the last twelve months to 3.91B, up 15.34% year-over-year. In the year 2023, Shenzhen Salubris Pharmaceuticals had annual revenue of 3.37B, down -3.35%.

• Revenue (ttm): 3.91B
• Revenue Growth: +15.34%
• P/S Ratio: 8.79
• Revenue / Employee: 1.11M
• Employees: 3,517
• Market Cap: 34.48B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	3.37B	-116.67M	-3.35%
Jan 1, 2023	3.48B	423.62M	13.85%
Jan 1, 2022	3.06B	319.83M	11.68%
Dec 31, 2020	2.74B	-1.73B	-38.74%
Dec 31, 2019	4.47B	-181.41M	-3.90%